Erasca to Present at Upcoming Investor Conferences

Rhea-AI Summary

Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company, has announced presentations at two upcoming investor conferences. The 5th Annual Evercore ISI HealthCONx Conference will be held virtually from November 29 to December 1, with a fireside chat scheduled for November 29 at 8:50 AM EST. Additionally, the Bank of America SMID Cap Conference is set for December 7-8, featuring a fireside chat on December 8 at 11:25 AM EST. Archived replays of both events will be available until February 2023. Visit Erasca.com/events for more details.

SAN DIEGO, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that company management will present at the following investor conferences:

5th Annual Evercore ISI HealthCONx Conference (November 29 – December 1, Virtual)
Format: Fireside Chat
Date and Time: Tuesday, November 29, 8:50 – 9:10 AM EST
Webcast: https://wsw.com/webcast/evercore29

Bank of America SMID Cap Conference (December 7 – 8, Virtual)
Format: Fireside Chat
Date and Time: Thursday, December 8, 11:25 – 11:55 AM EST
Webcast: https://bofa.veracast.com/webcasts/bofa

An archived replay of the events will be available until February 2023, following the webcast at Erasca.com/events.

About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of cancer. We have assembled what we believe to be the deepest RAS/MAPK pathway-focused pipeline in the industry. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.

Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com

Source: Erasca, Inc.

FAQ

What conferences will Erasca present at in November and December 2022?

Erasca will present at the 5th Annual Evercore ISI HealthCONx Conference from November 29 to December 1, and the Bank of America SMID Cap Conference on December 7-8.

What is the date and time of Erasca's fireside chat at the Evercore ISI HealthCONx Conference?

Erasca's fireside chat at the Evercore ISI HealthCONx Conference is scheduled for November 29, 2022, from 8:50 to 9:10 AM EST.

When will Erasca's fireside chat at the Bank of America SMID Cap Conference take place?

The fireside chat at the Bank of America SMID Cap Conference will occur on December 8, 2022, from 11:25 to 11:55 AM EST.

Where can I find the replays of Erasca's conference presentations?

Archived replays of Erasca's conference presentations will be available until February 2023 on their website at Erasca.com/events.

What is Erasca's focus in the oncology sector?

Erasca is focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.